Generics 5

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Pomalidomide manufacturers

5 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

5 products found

pomalidomide

Capsules 1 mg, 2 mg, 3 mg , 4 mg

Dossier type
EU CTD
Dossier status
Under development
Country of origin
India
GMP approvals
EU GMP
Unavailable markets
Chile , Panama , Mexico , Guatemala , Honduras , Nicaragua , El Salvador , Costa Rica , Belize , Haiti , Cuba , Dominican Republic , Jamaica , Bahamas , Barbados , Grenada , Antigua And/Or Barbuda , Dominica , Brazil , Colombia , Argentina , Peru , Venezuela , Ecuador , Bolivia , Paraguay , Uruguay , Suriname , Guyana
Available for
Licensing with supply
Manufacturer #261
A pharmaceutical manufacturer based in the EU that has been selling its products in Europe for 20+ years. Main therapeutic areas include diabetes, CNL, dermatology, and oncology. Main dosage forms include solid and liquid oral, sterile dosage forms, and ointments. The company possesses 10+ manufacturing facilities that are cGMP-compliant.

Manufacturer usually replies in 6 days

pomalidomide

Capsules 1 mg, 2 mg, 3 mg, 4 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA, Canada
Comments
Dossier availability: North America, Canada, Europe, United Kingdom, Latin America, Emerging Market
Manufacturer #16394

Manufacturer usually replies in 11 days

pomalidomide

Capsules 1 mg, 2 mg, 3 mg, 4 mg

Dossier type
US CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
FDA, EU GMP, WHO, MHRA, Canada
Comments
Dossier availability: North America, Canada, Europe, United Kingdom, Latin America, Emerging Market
Manufacturer #16394

Manufacturer usually replies in 11 days

pomalidomide

Vials, lyophilized injection 1 mg, 2 mg, 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #17753

Manufacturer usually replies in 10 days

pomalidomide

Capsules 4 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #30830

Manufacturer usually replies in nan days

Pomalidomide manufacturers

Multiple myeloma is treated with the drug pomalidomide (cancer resulting from a progressive blood disease). This pharmaceutical substance is typically used after at least two prior drugs have failed to work. When other drugs have failed or stopped working, It is used to treat AIDS-related Kaposi sarcoma. It is also used to treat Kaposi Sarcoma in HIV-negative people. It is only available through a special programme from a registered pharmacy. You must be enrolled in the programme and agree to take the necessary birth control precautions.

How does Pomalidomide work?

It works by slowing or preventing cancer cell proliferation. It is a drug that is used to treat a variety of malignancies (such as multiple myeloma, Kaposi sarcoma). It works by slowing or preventing cancer cell proliferation. The chemotherapeutic medication Pomalyst is marketed under the brand name pomalidomide. When talking about the generic medicine pomalidomide, health care providers may use the trade name Pomalyst. Pomalyst is only accessible as a brand name medicine; there is no generic equivalent presently. Take the capsules with or without food at roughly the same time each day. In a glass of water, swallow them whole. Chewing or opening the capsules is not advised. Whether you're a guy or a woman, use birth control to avoid pregnancy. For women, start using two types of birth control four weeks before you start taking it and stop four weeks after you stop. For men, use a condom to avoid conception while taking it and for up to four weeks after stopping it.

Pricing of Pomalidomide

Depending on the drugstore you visit, a supply of Pomalidomide oral capsule 1 mg costs roughly $19,908 for 21 capsules. Despite the fact that local rates are thought to be much lower than those in the United States, the patient pool that may be able to afford the treatment is being questioned.

Sourcing Pomalidomide Manufacturers and Suppliers

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Pomalidomide offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and this substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Pomalidomide. Also, each manufacturer or supplier product description contains essential information about this substance including clinical data, stability zones, countries where Pomalidomide is already registered inManufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over this medicine offer with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are boarded on the platform. This allows us to screen Pomalidomide manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.